Sinonasal CT scores were associated with several prognostic features in the disease course of chronic rhinosinusitis with nasal polyps, including blood eosinophil counts and risk of relapse after endoscopic sinus surgery.
Prognostic features and treatment outcomes in chronic rhinosinusitis with nasal polyps (CRSwNP) may be predicted by sinonasal CT scores, according to study findings published in Tomography.
In understanding the pathophysiology of CRSwNP, rhinologists consider the condition to consist of several endotypes that differ in disease recurrence risk and require targeted follow-up protocols and postoperative treatments.
With CT serving as the most common imaging modality in CRSwNP for the evaluation of inflammatory sinus mucosal disease, the present authors sought to assess whether it could predict the relationship of sinonasal inflammatory involvement with the clinical, laboratory, histopathological, and prognostic features of the condition.
Researchers used the Lund–Mackay score (LMS), the most widely applied CT staging system of sinonasal inflammatory changes, to examine in 78 patients the relationship with CRSwNP prior to and following endoscopic sinus surgery (ESS). Single paranasal subsite (maxillary, ethmoid, frontal, and sphenoid) and ostiomeatal complex (OMC) scores identified by the CT were also evaluated.
“Because of CT high spatial resolution and ability to depict fine osseous detail, it is the imaging test of choice for providing the necessary information for ESS planning,” they explained. “Such as the presence of fluid and degree of mucosal thickening, the presence of bone dehiscence or osteitis, and the anatomy of the sinuses, including important sinonasal anatomic variants.”
After assessing the association of LMS with clinical features, univariate logistic regression analysis findings indicated that ethmoid (odds ratio [OR], 1.358; P = .0496), sphenoid (OR, 1.722; P = .0335), OMC (OR, 1.706; P = .0235), and frontal (OR, 1.742; P = .0164) CT scores were predictive of nonsteroidal anti-inflammatory drugs (NSAIDs)-exacerbated respiratory disease (NERD), which was confirmed via the total CT score (OR, 1.193; P = .0062).
No significant differences were shown between patients with and without allergy regarding total and partial CT scores.
Regarding the association of LMS with laboratory results, high blood eosinophil counts (> 0.24 vs ≤ 0.24 cells × 10,9/L) were associated with total (OR, 1.106; P = .0213), maxillary (OR, 1.729; P = 0.0227) and ethmoid (OR, 1.200; P = .0491) CT scores in the univariate analysis. Moreover, higher ethmoid (OR, 1.399; P = .0006) and total sinonasal (OR, 1.142; P = .0027) CT scores were found to predict histopathologically eosinophil CRSwNPs.
“CT scores did not result as predictive of NSAID-exacerbated respiratory disease, asthma, or blood eosinophil count at the multivariate analysis,” noted the researchers.
Risk of relapse was also found to be related to the presence of NERD (HR, 3.914; 95% CI, 1.232-12.435; P = .0207), higher preoperative total score (HR, 1.098 95% CI, 1.001-1.204; P = .0486), and frontal sinus CT score (HR, 1.555; 95% CI, 1.006-1.886; P = .0218), but these results were not confirmed by the multivariable analysis.
“The preoperative sinonasal CT variables considered herein should be further investigated for their potential as a valuable aid in providing patients with correct information about prognosis and, mainly, to avoid generic treatments with poor outcomes,” concluded the study authors.
Reference
Brescia G, Contro G, Ruaro A, Frigo AC, Barion U, Marioni G. Preoperative sinonasal computed tomography score in chronic rhinosinusitis with nasal polyps. Tomography. 2022;8(1):77-88. doi:10.3390/tomography8010007
AI in Health Care: Closing the Revenue Cycle Gap
April 1st 2025This commentary explores the current state, challenges, and potential of artificial intelligence (AI) in health care revenue cycle management, emphasizing collaboration, data standardization, and targeted implementation to enhance adoption.
Read More
Managed Care Reflections: A Q&A With Hoangmai H. Pham, MD, MPH
April 1st 2025To mark the 30th anniversary of The American Journal of Managed Care® (AJMC®), each issue in 2025 will include a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The April issue features a conversation with Hoangmai H. Pham, MD, MPH, a member of AJMC’s editorial board and the president and CEO of the Institute for Exceptional Care (IEC).
Read More
Bridging Care Gaps With a Systemwide Value-Based Care Strategy
March 29th 2025Mapping care management needs by defining patient populations and then stratifying them according to risk and their needs can help to spur the transformation of a siloed health care system into an integrated system that is able to better provide holistic, value-based care despite the many transitions that continue among hospital, primary, specialty, and community care environments.
Read More